# Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial

> **NCT05744219** · PHASE3 · RECRUITING · sponsor: **Jon Unosson** · enrollment: 338 (estimated)

## Conditions studied

- Surgery
- Liver Metastases
- Liver Cancer
- Pancreas Cancer
- Aortic Aneurysm

## Interventions

- **DRUG:** Ferric carboxymaltose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05744219
- **Lead sponsor:** Jon Unosson
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-04
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-03-30
- **Target enrollment:** 338 (ESTIMATED)
- **Last updated:** 2024-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05744219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05744219, "Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05744219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*